miR-330-5p targets SPRY2 to promote hepatocellular carcinoma progression via MAPK/ERK signaling
2018 · Oncogenesis · 90 citations
https://doi.org/10.1038/s41389-018-0097-8
S
Shuai Xiao
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
64
Papers
994
Citations
14
h-index
16
i10-index
Shuai Xiao is an academic researcher from Hubei University of Technology. The author has contributed to research in topics: Gastric Cancer Management and Outcomes & Colorectal Cancer Treatments and Studies & Colorectal Cancer Surgical Treatments. The author has an h-index of 14, co-authored 55 publications.
ORCID: 0000-0003-0830-2188Papers by this author
worksACTL6A expression promotes invasion, metastasis and epithelial mesenchymal transition of colon cancer
2018 · BMC Cancer · 69 citations
https://doi.org/10.1186/s12885-018-4931-3
Epigenetic modification and BRAF gene mutation in thyroid carcinoma
2021 · Cancer Cell International · 29 citations
https://doi.org/10.1186/s12935-021-02405-w
The effect of marital and insurance status on the survival of elderly patients with stage M1b colon cancer: a SEER-based study
2021 · BMC Cancer · 26 citations
https://doi.org/10.1186/s12885-021-08627-5
The tripartite motif-containing 24 is a multifunctional player in human cancer
2024 · Cell & Bioscience · 14 citations
https://doi.org/10.1186/s13578-024-01289-3
Sulfasalazine-loaded nanoframes: A new frontier in bladder cancer therapy through ferroptosis induction
2024 · Colloids and Surfaces B Biointerfaces · 10 citations
https://doi.org/10.1016/j.colsurfb.2024.114394
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat